Oncobiologics, Inc. will debut at the 2011 BIO International Convention, which is being held June 27-30 in Washington, DC. Founded by a group of scientists and engineers from such companies as Genentech, Eli Lilly, Bristol-Myers Squibb, Bayer, Merck, Johnson & Johnson, Schering-Plough and Medarex, Oncobiologics is commercializing a new one-stop proof-of-concept “engine” that will enable biologic drug developers to “economically and efficiently develop more of their preclinical drug can...